Group 1 - The company is celebrating the one-year anniversary of its CEO, Paul LaViolette, who joined just before JPMorgan's event in 2025, reflecting on the past year's accomplishments and future outlook for 2026 [2] - The company's mission focuses on capitalizing on its exclusive control over nanosecond pulsed field ablation (PFA), which is recognized for its unique energy in pulsed electric fields, providing both technical and clinical advantages [3] Group 2 - The company aims to build a viable and thriving business, leveraging its unique technology in the PFA sector [4]